Diisopropylethylamine → HCID 10136280, 화합물

HRID 1432408노트

반응식

HRID 1432408 반응식
[CH2:1]([NH:8][C:9]1[N:17]=[C:16](F)[N:15]=[C:14]2[C:10]=1[N:11]=[CH:12][N:13]2[CH:19]([CH3:21])[CH3:20])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.CCN(C(C)C)C(C)C.[NH2:31][C@H:32]([CH2:39][CH3:40])[CH:33]([OH:38])[C:34]([CH3:37])([CH3:36])[CH3:35]>CCCCO.CS(C)=O>[CH2:1]([NH:8][C:9]1[N:17]=[C:16]([NH:31][C@H:32]([CH2:39][CH3:40])[CH:33]([OH:38])[C:34]([CH3:37])([CH3:36])[CH3:35])[N:15]=[C:14]2[C:10]=1[N:11]=[CH:12][N:13]2[CH:19]([CH3:21])[CH3:20])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1

참가 물질

5

반응물 3

HCID 81531DiisopropylethylamineHCID 17954009Benzyl-(2-fluoro-9-isopropyl-9H-purin-6-yl)-amineHCID 57714163(3RS,4R)-4-amino-2,2-dimethyl-hexan-3-ol

생성물 1

HCID 10136280HCID 10136280, 화합물

시약·촉매·용매 1

HCID 20476217n-BuOH DMSO용매

실험 절차

To a stirred solution of benzyl-(2-fluoro-9-isopropyl-9H-purin-6-yl)-amine (40 mg, 1 eq, 0.14 mmol) in n-BuOH/DMSO (5 mL, 4:1) at room temperature under an argon atmosphere was added DIEA (0.12 mL, 4.9 eq, 0.69 mmol) followed by (3RS,4R)-4-amino-2,2-dimethyl-hexan-3-ol (69 mg, 3.4 eq, 0.48 mmol). The reaction mixture was placed in a preheated oil bath at 140° C. and stirred at this temperature for 72 h. The reaction mixture was allowed to cool to room temperature and the solvent was evaporated in vacuo. The residue was partitioned between EtOAc (50 mL) and brine/water (1:1, 100 mL), the aqueous phase was extracted with more EtOAc (2×50 mL), and the combined organic phase was washed with brine (50 mL), dried (MgSO4) and evaporated in vacuo. The residue was purified by gradient column chromatography on silica gel eluted with hexane:ether:MeOH (50:50:0→50:50:2) to afford the title compound as a white solid; Yield: 13 mg (23%).(55% de 4R,3S: 45% de 4R,3R). 1H-NMR (d-CDCl3, 250 MHz): δ 1.00-1.04 (m, 12H, —NHCH(CH2CH3)CH(C(CH3)3)OH), 1.56+1.58 (2×d, 6H, J=6.63+6.79 Hz, —CH(CH3)2), 1.63-1.87 (m, 2H, —NHCH(CH2CH3)CH(C(CH3)3)OH), 3.57 (d, 1H, J=1.42 Hz, —NHCH(CH2CH3) CH(C(CH3)3)OH), 3.73-3.87 (m, 1H, —NHCH(CH2CH3)CH(C(CH3)3)OH), 4.57-4.70 (m, 1H, —CH(CH3)2), 4.77-4.86 (m, 2H, —HNCH2-Bz), 5.22-5.36+5.93-6.09 (2×m, 1H, —NHCH(CH2CH3)CH(C(CH3)3)OH), 7.25-7.44 (m, 6H, 5×Bz-H+HNCH2-Bz), 7.53 (s, 1H, —N═CH—N). FABMS m/z (relative intensity): 411 ([M+H]+, 90), 323 (100). Accurate Mass (M+H): Actual: 411.2872, Measured: 411.2860.

후처리

  1. customThe reaction mixture was placed in a preheated oil bath at 140° C.
  2. customthe solvent was evaporated in vacuo
  3. customThe residue was partitioned between EtOAc (50 mL) and brine/water (1:1, 100 mL)
  4. extractionthe aqueous phase was extracted with more EtOAc (2×50 mL)
  5. washthe combined organic phase was washed with brine (50 mL)
  6. dry with materialdried (MgSO4)
  7. customevaporated in vacuo
  8. customThe residue was purified by gradient column chromatography on silica gel
  9. washeluted with hexane:ether:MeOH (50:50:0→50:50:2)

출처 및 근거

ORD 기록
ord-157ab4ff773549d09a829cc2b9022ea1
출처 데이터셋
uspto-grants-2009_11
특허 번호
US07612079B2

반응 노트

불러오는 중…